Literature DB >> 24290388

Orchestration of neurodevelopmental programs by RBFOX1: implications for autism spectrum disorder.

Brent R Bill1, Jennifer K Lowe, Christina T Dybuncio, Brent L Fogel.   

Abstract

Neurodevelopmental and neuropsychiatric disorders result from complex interactions between critical genetic factors and as-yet-unknown environmental components. To gain clinical insight, it is critical to develop a comprehensive understanding of these genetic components. RBFOX1, an RNA splicing factor, regulates expression of large genetic networks during early neuronal development, and haploinsufficiency causes severe neurodevelopmental phenotypes including autism spectrum disorder (ASD), intellectual disability, and epilepsy. Genomic testing in individuals and large patient cohorts has identified phenotypically similar cases possessing copy number variations in RBFOX1, implicating the gene as an important cause of neurodevelopmental disease. However, a significant proportion of the observed structural variation is inherited from phenotypically normal individuals, raising questions regarding overall pathogenicity of variation at the RBFOX1 locus. In this chapter, we discuss the molecular, cellular, and clinical evidence supporting the role of RBFOX1 in neurodevelopment and present a comprehensive model for the contribution of structural variation in RBFOX1 to ASD.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  A2BP1; Autism; Autism spectrum disorder; Copy number variation; FOX1; Neurodevelopment; RBFOX1; RNA splicing

Mesh:

Substances:

Year:  2013        PMID: 24290388      PMCID: PMC4318517          DOI: 10.1016/B978-0-12-418700-9.00008-3

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  66 in total

1.  RBFOX1 regulates both splicing and transcriptional networks in human neuronal development.

Authors:  Brent L Fogel; Eric Wexler; Amanda Wahnich; Tara Friedrich; Chandran Vijayendran; Fuying Gao; Neelroop Parikshak; Genevieve Konopka; Daniel H Geschwind
Journal:  Hum Mol Genet       Date:  2012-06-23       Impact factor: 6.150

2.  Microduplications disrupting the MYT1L gene (2p25.3) are associated with schizophrenia.

Authors:  Yohan Lee; Anand Mattai; Robert Long; Judith L Rapoport; Nitin Gogtay; Anjené M Addington
Journal:  Psychiatr Genet       Date:  2012-08       Impact factor: 2.458

3.  A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.

Authors:  Janghoo Lim; Tong Hao; Chad Shaw; Akash J Patel; Gábor Szabó; Jean-François Rual; C Joseph Fisk; Ning Li; Alex Smolyar; David E Hill; Albert-László Barabási; Marc Vidal; Huda Y Zoghbi
Journal:  Cell       Date:  2006-05-19       Impact factor: 41.582

4.  Rare inherited A2BP1 deletion in a proband with autism and developmental hemiparesis.

Authors:  L K Davis; N Maltman; M W Mosconi; C Macmillan; L Schmitt; K Moore; S M Francis; S Jacob; J A Sweeney; E H Cook
Journal:  Am J Med Genet A       Date:  2012-06-07       Impact factor: 2.802

5.  Celsius: a community resource for Affymetrix microarray data.

Authors:  Allen Day; Marc R J Carlson; Jun Dong; Brian D O'Connor; Stanley F Nelson
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

6.  Rare chromosomal deletions and duplications increase risk of schizophrenia.

Authors: 
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

Review 7.  Sleep problems in autism spectrum disorders: prevalence, nature, & possible biopsychosocial aetiologies.

Authors:  Amanda L Richdale; Kimberly A Schreck
Journal:  Sleep Med Rev       Date:  2009-04-24       Impact factor: 11.609

8.  Strong association of de novo copy number mutations with autism.

Authors:  Jonathan Sebat; B Lakshmi; Dheeraj Malhotra; Jennifer Troge; Christa Lese-Martin; Tom Walsh; Boris Yamrom; Seungtai Yoon; Alex Krasnitz; Jude Kendall; Anthony Leotta; Deepa Pai; Ray Zhang; Yoon-Ha Lee; James Hicks; Sarah J Spence; Annette T Lee; Kaija Puura; Terho Lehtimäki; David Ledbetter; Peter K Gregersen; Joel Bregman; James S Sutcliffe; Vaidehi Jobanputra; Wendy Chung; Dorothy Warburton; Mary-Claire King; David Skuse; Daniel H Geschwind; T Conrad Gilliam; Kenny Ye; Michael Wigler
Journal:  Science       Date:  2007-03-15       Impact factor: 47.728

9.  Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism.

Authors:  Christa Lese Martin; Jacqueline A Duvall; Yesim Ilkin; Jason S Simon; M Gladys Arreaza; Kristin Wilkes; Ana Alvarez-Retuerto; Amy Whichello; Cynthia M Powell; Kathleen Rao; Edwin Cook; Daniel H Geschwind
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-10-05       Impact factor: 3.568

10.  Intragenic deletion of RBFOX1 associated with neurodevelopmental/neuropsychiatric disorders and possibly other clinical presentations.

Authors:  Wei-Wei Zhao
Journal:  Mol Cytogenet       Date:  2013-07-03       Impact factor: 2.009

View more
  32 in total

Review 1.  MECHANISMS IN ENDOCRINOLOGY: Alternative splicing: the new frontier in diabetes research.

Authors:  Jonàs Juan-Mateu; Olatz Villate; Décio L Eizirik
Journal:  Eur J Endocrinol       Date:  2015-12-01       Impact factor: 6.664

2.  Rbfox Proteins Regulate Splicing as Part of a Large Multiprotein Complex LASR.

Authors:  Andrey Damianov; Yi Ying; Chia-Ho Lin; Ji-Ann Lee; Diana Tran; Ajay A Vashisht; Emad Bahrami-Samani; Yi Xing; Kelsey C Martin; James A Wohlschlegel; Douglas L Black
Journal:  Cell       Date:  2016-04-21       Impact factor: 41.582

3.  Systems genetics analysis of pharmacogenomics variation during antidepressant treatment.

Authors:  M B Madsen; L J A Kogelman; H N Kadarmideen; H B Rasmussen
Journal:  Pharmacogenomics J       Date:  2016-10-18       Impact factor: 3.550

Review 4.  Pharmacogenetic Correlates of Antipsychotic-Induced Weight Gain in the Chinese Population.

Authors:  Chao Luo; Junyan Liu; Xu Wang; Xiaoyuan Mao; Honghao Zhou; Zhaoqian Liu
Journal:  Neurosci Bull       Date:  2019-01-03       Impact factor: 5.203

Review 5.  Developmental regulation of RNA processing by Rbfox proteins.

Authors:  John G Conboy
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-10-17       Impact factor: 9.957

Review 6.  Novel Insights into NeuN: from Neuronal Marker to Splicing Regulator.

Authors:  Wei Duan; Yu-Ping Zhang; Zhi Hou; Chen Huang; He Zhu; Chun-Qing Zhang; Qing Yin
Journal:  Mol Neurobiol       Date:  2015-02-14       Impact factor: 5.590

7.  Splicing Activation by Rbfox Requires Self-Aggregation through Its Tyrosine-Rich Domain.

Authors:  Yi Ying; Xiao-Jun Wang; Celine K Vuong; Chia-Ho Lin; Andrey Damianov; Douglas L Black
Journal:  Cell       Date:  2017-07-13       Impact factor: 41.582

Review 8.  Alternative splicing as a regulator of development and tissue identity.

Authors:  Francisco E Baralle; Jimena Giudice
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-10       Impact factor: 94.444

Review 9.  Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders.

Authors:  Vittoria Pagliarini; Piergiorgio La Rosa; Claudio Sette
Journal:  Hum Genet       Date:  2017-04-22       Impact factor: 4.132

10.  Genome Sequencing of Autism-Affected Families Reveals Disruption of Putative Noncoding Regulatory DNA.

Authors:  Tychele N Turner; Fereydoun Hormozdiari; Michael H Duyzend; Sarah A McClymont; Paul W Hook; Ivan Iossifov; Archana Raja; Carl Baker; Kendra Hoekzema; Holly A Stessman; Michael C Zody; Bradley J Nelson; John Huddleston; Richard Sandstrom; Joshua D Smith; David Hanna; James M Swanson; Elaine M Faustman; Michael J Bamshad; John Stamatoyannopoulos; Deborah A Nickerson; Andrew S McCallion; Robert Darnell; Evan E Eichler
Journal:  Am J Hum Genet       Date:  2015-12-31       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.